On Invalid Date, Soleno Therapeutics (NASDAQ: SLNO) reported Q2 2023 earnings per share (EPS) of -$0.81, up 12.5% year over year. Total Soleno Therapeutics earnings for the quarter were -$8.48 million. In the same quarter last year, Soleno Therapeutics's earnings per share (EPS) was -$0.72.
As of Q4 2023, Soleno Therapeutics's earnings has grown year over year. Soleno Therapeutics's earnings in the past year totalled -$28.45 million.
What is SLNO's earnings date?
Soleno Therapeutics's earnings date is Invalid Date. Add SLNO to your watchlist to be reminded of SLNO's next earnings announcement.
What was SLNO's revenue last quarter?
On Invalid Date, Soleno Therapeutics (NASDAQ: SLNO) reported Q2 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Soleno Therapeutics's revenue was $0.00.
What was SLNO's revenue growth in the past year?
As of Q4 2023, Soleno Therapeutics's revenue has grown null year over year. Soleno Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.